The Role of Amphetamines in Treating POTS

Postural Orthostatic Tachycardia Syndrome (POTS) is a challenging condition characterized by a significant increase in heart rate upon standing, leading to a host of symptoms including dizziness, fatigue, and cognitive impairment, commonly referred to as "brain fog." While traditional treatments, like fludrocortisone and beta-blockers, are often used to manage POTS, they don't always provide sufficient relief. This has led to growing interest in the use of amphetamines as an alternative treatment option, particularly for patients whose symptoms are refractory, or resistant, to standard therapies.

Please keep in mind that this article is not medical advice. You should consult your doctor for diagnosis and treatment of any condition. We do not prescribe any amphetamines or stimulant medications. This article is provided for informational purposes only.

‍

Understanding Amphetamines in POTS Treatment

Amphetamines are central nervous system stimulants commonly prescribed for Attention Deficit Disorder (ADD). Amphetamine type medications include medications like dextroamphetamine (Adderall), methylphenidate (Ritalin, Concerta), and lisdexamfetamine (Vyvanse). Their application in POTS focuses on their ability to alleviate two of the most debilitating symptoms: fatigue and brain fog.

Mechanism of Action of Amphetamines:

Amphetamines work by increasing the levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine. This action helps improve focus, wakefulness, and energy levels. For POTS patients, this can translate into reduced fatigue and enhanced cognitive function, making daily activities more manageable. Additionally, amphetamines cause vasoconstriction, which can raise blood pressure—a benefit for POTS patients who often struggle with low blood pressure and related symptoms.
‍

Why are Amphetamines used to treat POTS?

1. Boosting Energy and Wakefulness: They enhance wakefulness and energy levels, which can be particularly beneficial for POTS patients suffering from chronic fatigue.
2. Improving Cognitive Function: The increase in dopamine and norepinephrine helps clear brain fog, making it easier for patients to concentrate and process information.
3. Raising Blood Pressure: By causing blood vessels to constrict, amphetamines can help raise blood pressure, combating one of the core issues in POTS, which is often characterized by low blood pressure and poor circulation when standing.

‍

Clinical Evidence Supporting Amphetamines in POTS

Several studies have examined the effectiveness of amphetamines in treating POTS, especially in cases where other treatments have failed:

1. Methylphenidate: A study by Kanjwal et al. (2012) involving 24 POTS patients found that 77% of participants experienced significant improvements in symptoms such as fatigue and presyncope (feeling faint) after being treated with methylphenidate​. This suggests that methylphenidate could be a viable option for those with refractory POTS.
2. Lisdexamfetamine: Another study highlighted the use of lisdexamfetamine in treating executive functioning deficits and chronic fatigue, showing promising results in reducing the overall symptom burden for POTS patients​.
3. Modafinil: Although not a traditional stimulant, modafinil has also been studied for its potential to improve wakefulness in POTS patients. A randomized control study demonstrated significant improvements in cognitive symptoms secondary to POTS, making it another potential option for managing brain fog and fatigue​.

Advantages and Limitations

Advantages:

• Symptom Relief: Amphetamines have shown significant potential in reducing fatigue, improving mental clarity, and even helping to manage heart rate and blood pressure in POTS patients.
• Increased Quality of Life: By managing these symptoms, patients often experience a notable improvement in their ability to perform daily activities.

Limitations:

• Side Effects: Like all medications, amphetamines can have side effects, including anxiety, tremors, and increased heart rate, which may exacerbate some POTS symptoms.
• Research Gaps: Despite promising results, studies on amphetamines for POTS have limitations, such as small sample sizes and a lack of double-blind, placebo-controlled trials. More extensive research is needed to confirm long-term safety and efficacy​.

Considerations for the use of Amphetamines in POTS treatment

If considering amphetamines for POTS, here are some general guidelines:

• Start Low, Go Slow: Begin with a low dose, such as 5 mg of dextroamphetamine or 20 mg of lisdexamfetamine in the morning. Adjust the dosage gradually based on the patient's response.
• Monitor Closely: Keep a close watch for any side effects. If adverse reactions like rapid heartbeat or significant anxiety occur, the medication should be reassessed.
• Consider Alternatives: Modafinil may be an alternative for those who cannot tolerate traditional stimulants but still need help with wakefulness.

‍

Conclusion

The use of amphetamines offers a promising avenue for managing refractory POTS, particularly in patients struggling with severe fatigue and cognitive impairment. While these medications are not without risks, their potential benefits make them a viable option for many patients. As with any treatment, it’s crucial to consult with a healthcare provider to tailor the approach to the individual’s specific needs and to monitor for any potential side effects. Continued research will be key to fully understanding the role of amphetamines in POTS and optimizing treatment protocols for those affected by this challenging condition.

You should consult with a physician for medical care. This article is not medical advice and should not be used for diagnosis or treatment of any medical condition.

‍

References

1. Kanjwal, K., Saeed, B., Karabin, B., Kanjwal, Y., & Grubb, B. P. (2012). Use of Methylphenidate in the Treatment of Patients Suffering from Refractory Postural Tachycardia Syndrome. American Journal of Therapeutics, 19(1), 2-6. doi:10.1097/mjt.0b013e3181dd21d2.
2. Young, J. (2012). Use of Lisdexamfetamine Dimesylate in Treatment of Executive Functioning Deficits and Chronic Fatigue Syndrome: A Double-Blind, Placebo-Controlled Study. Psychiatry Research. doi:10.1016/j.psychres.2012.09.007.
3. Kpaeyeh, A. G., Mar, P. L., Raj, V., Black, B. K., Arnold, A. C., Biaggioni, I., & Raj, S. R. (2014). Hemodynamic Profiles and Tolerability of Modafinil in the Treatment of POTS: A Randomized Placebo-Controlled Trial. Journal of Clinical Psychopharmacology, 34(6), 738–741. doi:10.1097/JCP.0000000000000221​​.
4. Standing Up to POTS. (n.d.). Treating Brain Fog and Fatigue in POTS. Retrieved August 20, 2024, from https://www.standinguptopots.org/resources/medicine
5. Dysautonomia International. (n.d.). Cognitive Dysfunction and Brain Fog in POTS. Retrieved August 20, 2024, from https://dysautonomiainternational.org/blog/wordpress/cognitive-dysfunction-and-brain-fog-in-pots/

‍